Neuropsychiatric manifestations such as depression, anxiety, and cognitive decline are prevalent complications in PD that contribute to a reduction in patient quality of life. Over 50% of PD patients experience depression and anxiety, while 80% experience cognitive decline (Weintraub and Burn 2011). Unfortunately there are no effective pharmacological treatments for mood disturbances or cognitive dysfunction in PD. Emerging evidence suggests that psychotherapy approaches are beneficial for the treatment of depression and anxiety in PD. This study examines the benefits of tailored therapy methods to alleviate motor symptoms and non-motor symptoms of PD, and to improve the psychological well-being and quality of life of people with PD.